{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"}],"units":"Participants"}],"description":"Overall response rate is defined as the percentage of patients with disease progression. Progression is defined as:\n\n* Appearance of a new lesion on fluorodeoxyglucose (FDG)-positron emission tomography or computerized tomography\n* ≥50% increase in sum of the product of the node dimensions (SPD) of more than one node or in greatest diameter of any previously identified node \\>1 cm in its short axis from nadir.\n* To be considered progressive disease, a lymph node with a diameter of the short axis of less than 1.0 cm must increase by 50% and to a size of 1.5 x 1.5 cm or more than 1.5 cm in the long axis.\n* At least a 50% increase in the longest diameter of any single previously identified node more than 1 cm in its short axis.","groups":[{"description":"Doxycycline 200 mg twice daily\n\nDoxycycline","id":"OG000","title":"Doxycycline"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Three months","title":"Overall Response Rate","type":"PRIMARY","unitOfMeasure":"percentage of participants"}